Hunter named as American Epilepsy Society Sergievsky Scholar June 27, 2022 Senyenne Hunter, MD, PhD, is one of two recipients who are the first grantees to receive the award.
Powers to Retire from UNC after 15 years of Service June 15, 2022 William J. Powers, MD, Professor of Neurology and former department chair (April 2007 – April 2018) to retire on June 30.
Powers to Retire from UNC after 15 years of Service May 9, 2022 William J. Powers, MD, Professor of Neurology and former department chair (April 2007 – April 2018) to retire on June 30. Dr. Powers was recruited to UNC from Washington University School of Medicine in 2007 to chair the Department. He received his MD from Cornell University and was an intern...
Scientists Detail Brain Dynamics Implicated in Neurological Conditions May 5, 2022 UNC School of Medicine researchers led by Ian Shih, PhD, used fMRI and a genetic mouse model to study the effects of a neurotransmitter on brain network functional connectivity, a dynamic process crucial for human health and behavior.
FDA Approves Treatment for Myasthenia Gravis After Phase III Study Led by James Howard, MD May 5, 2022 James F. Howard, Jr, MD, in the UNC Department of Neurology is the lead primary investigator in the CHAMPION-MG trial for Ultomiris (ravulizumab-cwvz) as a treatment for adults with generalised myasthenia gravis who are anti-acetylcholine receptor antibody-positive, which represents 80% of people living with the disease.
Hunter named as Simmons Scholar May 2, 2022 Dr. Senyene Hunter, assistant professor of child neurology, was named as a UNC School of Medicine Simmons Scholar, effective July 2022.
Interim Data Suggest Long-term Treatment with VYVGART Provides Improvement in Generalized Myasthenia Gravis Disease Scores April 7, 2022 James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the ADAPT+ trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
UNC Neurologists Elected to AAN Section Leadership April 2, 2022 Monica Diaz, MD, MS, and Ana Felix, MBBCH, FAAN, have been elected as the 2022-2023 Vice Chairs of the American Academy of Neurology’s Global Health Section and the AB Baker Section for Neurological Education, respectively.
Traub and Li awarded $5K-50K NC TraCS grant March 1, 2022 NC TraCS awarded funding for a $5K-$50K grant application submitted by Rebecca Traub, MD and Xiaoyan Li, MD, PhD.
FDA approves new drug to treat generalized myasthenia gravis January 3, 2022 James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.